Search

Search Results
Results 7331 - 7340 of 7381 for autoimmune
  • News - 12 Mar 2010
    GTC Biotherapeutics, Inc. today reported its financial results for the fourth quarter and fiscal year ended January 3, 2010. The total net loss for the fourth quarter was $1.7 million, or $0.09 per...
  • White Paper - 27 Oct 2025
    Explore how Incucyte® apoptosis assays enable real-time, quantitative analysis of programed cell death.
  • White Paper - 6 Mar 2019
    Using an APCI LC-MS/MS mass spectrometry system to perform the analysis of vitamin D in cheese.
  • Health - 27 Feb 2019
    Rickets has been around for centuries, but its roots as a symptom of vitamin D deficiency began only in the 17th century, when Francis Glisson published his findings on the disease and proposed that...
  • News - 18 Feb 2010
    Incyte Corporation today reported fourth quarter and full year 2009 financial results, provided an update on key fourth quarter accomplishments and 2010 objectives, and announced its 2010 financial...
  • Drug - 7 May 2026
    Consumer Medicine Information (CMI) about Triasyn intended for persons living in Australia.
  • Drug - 31 Mar 2026
    Consumer Medicine Information (CMI) about Shingrix intended for persons living in Australia.
  • Drug - 27 Feb 2026
    Consumer Medicine Information (CMI) about Intelence intended for persons living in Australia.
  • Drug - 21 Jan 2026
    Consumer Medicine Information (CMI) about Remicade intended for persons living in Australia.
  • Drug - 5 Jan 2026
    Consumer Medicine Information (CMI) about Xadago intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.